Modeling 5-FU-Induced Chemotherapy Selection of a Drug-Resistant Cancer Stem Cell Subpopulation

被引:0
|
作者
Hamzagic, Amra Ramovic [1 ,2 ]
Cvetkovic, Danijela [1 ,2 ]
Jankovic, Marina Gazdic [1 ,2 ]
Dimitrijevic, Nevena Milivojevic [3 ]
Nikolic, Dalibor [3 ,4 ]
Zivanovic, Marko [3 ]
Kastratovic, Nikolina [1 ,2 ]
Petrovic, Ivica [5 ]
Nikolic, Sandra [1 ,2 ]
Jovanovic, Milena [6 ]
Seklic, Dragana [3 ]
Filipovic, Nenad [4 ,7 ]
Ljujic, Biljana [1 ,2 ]
机构
[1] Univ Kragujevac, Fac Med Sci, Dept Genet, Kragujevac 34000, Serbia
[2] Univ Kragujevac, Fac Med Sci, Serbia Harm Reduct Biol & Chem Hazards, Kragujevac 34000, Serbia
[3] Univ Kragujevac, Inst Informat Technol Kragujevac, Liceja Knezevine Srbije 1A, Kragujevac 34000, Serbia
[4] Bioengn Res & Dev Ctr BioIRC, Prvoslava Stojanov 6, Kragujevac 34000, Serbia
[5] Univ Kragujevac, Fac Med Sci, Dept Pathophysiol, Kragujavac 34000, Serbia
[6] Univ Kragujevac, Fac Sci, Radoja Domanovica 12, Kragujevac 34000, Serbia
[7] Univ Kragujevac, Fac Engn, Sestre Janjic 6, Kragujevac 34000, Serbia
关键词
cancer stem cells; chemotherapy resistance; machine learning model; PREDICTION;
D O I
10.3390/curroncol31030091
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
(1) Background: Cancer stem cells (CSCs) are a subpopulation of cells in a tumor that can self-regenerate and produce different types of cells with the ability to initiate tumor growth and dissemination. Chemotherapy resistance, caused by numerous mechanisms by which tumor tissue manages to overcome the effects of drugs, remains the main problem in cancer treatment. The identification of markers on the cell surface specific to CSCs is important for understanding this phenomenon. (2) Methods: The expression of markers CD24, CD44, ALDH1, and ABCG2 was analyzed on the surface of CSCs in two cancer cell lines, MDA-MB-231 and HCT-116, after treatment with 5-fluorouracil (5-FU) using flow cytometry analysis. A machine learning model (ML)-genetic algorithm (GA) was used for the in silico simulation of drug resistance. (3) Results: As evaluated through the use of flow cytometry, the percentage of CD24-CD44+ MDA-MB-231 and CD44, ALDH1 and ABCG2 HCT-116 in a group treated with 5-FU was significantly increased compared to untreated cells. The CSC population was enriched after treatment with chemotherapy, suggesting that these cells have enhanced drug resistance mechanisms. (4) Conclusions: Each individual GA prediction model achieved high accuracy in estimating the expression rate of CSC markers on cancer cells treated with 5-FU. Artificial intelligence can be used as a powerful tool for predicting drug resistance.
引用
收藏
页码:1221 / 1234
页数:14
相关论文
共 50 条
  • [31] Cell death induced by novel fluorinated taxanes in drug-sensitive and drug-resistant cancer cells
    Voborilova, Jana
    Nemcova-Fuerstova, Vlasta
    Neubauerova, Jitka
    Ojima, Iwao
    Zanardi, Ilaria
    Gut, Ivan
    Kovar, Jan
    INVESTIGATIONAL NEW DRUGS, 2011, 29 (03) : 411 - 423
  • [32] Cell death induced by novel fluorinated taxanes in drug-sensitive and drug-resistant cancer cells
    Jana Vobořilová
    Vlasta Němcová-Fürstová
    Jitka Neubauerová
    Iwao Ojima
    Ilaria Zanardi
    Ivan Gut
    Jan Kovář
    Investigational New Drugs, 2011, 29 : 411 - 423
  • [33] 5-FU-induced neurotoxicity in cancer patients with profound DPD deficiency syndrome: a report of two cases
    Pierre-Yves Cordier
    André Nau
    Joseph Ciccolini
    Manuela Oliver
    Cédric Mercier
    Bruno Lacarelle
    Eric Peytel
    Cancer Chemotherapy and Pharmacology, 2011, 68 : 823 - 826
  • [34] A recurrent colorectal cancer case with 5-FU-induced hyperammonemic encephalopathy, continuously receiving a reduced dose
    Suto, Hirotaka
    Onishi, Akio
    Shigeoka, Yasushi
    ANNALS OF ONCOLOGY, 2015, 26 : 117 - 117
  • [35] 5-FU-induced neurotoxicity in cancer patients with profound DPD deficiency syndrome: a report of two cases
    Cordier, Pierre-Yves
    Nau, Andre
    Ciccolini, Joseph
    Oliver, Manuela
    Mercier, Cedric
    Lacarelle, Bruno
    Peytel, Eric
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2011, 68 (03) : 823 - 826
  • [36] Adenosine-based stem cell therapy for drug-resistant epilepsy
    Gouder, N
    Fedele, DE
    Güttinger, M
    Möhler, H
    Pralong, WF
    Aebischer, P
    Koch, P
    Brustle, O
    Boison, D
    PHARMACOLOGY, 2004, 72 (02) : 149 - 149
  • [37] Drug-Resistant Stem Cells: Novel Approach for Colon Cancer Therapy
    Telang, Nitin
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2022, 23 (05)
  • [38] Characterization of a novel dormant, drug resistant, stem cell subpopulation in acute lymphoblastic leukemia
    Ebinger, S.
    Ozdemir, E.
    Tiedt, S.
    Ziegenhain, C.
    Castro-Alves, C.
    Enard, W.
    Jeremias, I.
    EUROPEAN JOURNAL OF CANCER, 2016, 61 : S207 - S207
  • [39] Generation and molecular profiling of drug-resistant cancer cell lines
    He, Fang
    Pan, Pengwei
    Yuan, Zengjin
    Huang, Jingqi
    CANCER RESEARCH, 2016, 76
  • [40] Antiangiogenic scheduling of chemotherapy improves efficacy against experimental drug-resistant cancer
    Browder, T
    Butterfield, CE
    Kräling, BM
    Shi, B
    Marshall, B
    O'Reilly, MS
    Folkman, J
    CANCER RESEARCH, 2000, 60 (07) : 1878 - 1886